Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 1/20 | 0.45 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.39 |
| ▸ | LPAR3 | Q9UBY5 | 2/20 | 0.39 |
| ▸ | SMPD1 | P17405 | 3/20 | 0.38 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.38 |
| ▸ | FDPS | P14324 | 3/20 | 0.38 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.38 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | LCK | P06239 | 1/20 | 0.36 |
| ▸ | PPARD | Q03181 | 1/20 | 0.36 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.36 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL250415 | 1.00 | DNM1 (0.45) | DNM1LPAR1LPAR3SMPD1GPR84 | |
| SCHEMBL2531986 | 1.00 | DNM1 (0.45) | DNM1LPAR1LPAR3SMPD1GPR84 | |
| SCHEMBL11131659 | 1.00 | DNM1 (0.45) | DNM1LPAR1LPAR3SMPD1GPR84 | |
| SCHEMBL459228 | 1.00 | DNM1 (0.45) | DNM1LPAR1LPAR3SMPD1GPR84 | |
| SCHEMBL4655596 | 1.00 | DNM1 (0.45) | DNM1LPAR1LPAR3SMPD1GPR84 | |
| SCHEMBL6554402 | 1.00 | DNM1 (0.45) | DNM1LPAR1LPAR3SMPD1GPR84 | |
| SCHEMBL3806150 | 1.00 | DNM1 (0.45) | DNM1LPAR1LPAR3SMPD1GPR84 | |
| SCHEMBL1111104 | 0.98 | DNM1 (0.44) | DNM1LPAR1LPAR3SMPD1GPR84 | |
| SCHEMBL5936869 | 0.96 | DNM1 (0.42) | DNM1LPAR1LPAR3SMPD1GPR84 | |
| SCHEMBL1608844 | 0.96 | DNM1 (0.42) | DNM1LPAR1LPAR3SMPD1GPR84 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3073263-B1 | DEVICE, COMPOSITION AND METHOD FOR TISSUE-BASED DIAGNOSIS | UNIV CALIFORNIA (US) | 2020-04-29 | — | — | EP | claimed |
| US-9848853-B2 | System, method and devices for tissue-based diagnosis | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2017-12-26 | — | — | US | claimed |
| CN-106420667-A | A novel formulation of diclofenac | 伊休蒂卡有限公司 | 2017-02-22 | — | — | CN | claimed |
| EP-3073263-A1 | SYSTEM, METHOD AND DEVICE FOR TISSUE-BASED DIAGNOSIS | The Regents of the University of California (US) | 2016-09-28 | — | — | EP | claimed |
| CN-105919939-A | Production of encapsulated nanoparticles at commercial scale | 伊休蒂卡有限公司 | 2016-09-07 | — | — | CN | claimed |
| US-20160235392-A1 | SYSTEM, METHOD AND DEVICES FOR TISSUE-BASED DIAGNOSIS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2016-08-18 | — | — | US | claimed |
| CN-105663045-A | Production of encapsulated nanoparticles at high volume fractions | 伊休蒂卡有限公司 | 2016-06-15 | — | — | CN | claimed |
| US-9328324-B2 | System, method and devices for tissue-based diagnosis | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2016-05-03 | — | — | US | claimed |
| US-20150344834-A1 | System, Method and Devices for Tissue-Based Diagnosis | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2015-12-03 | — | — | US | claimed |
| CN-104825396-A | Method for improving dissolution profile of biologically active material | ICEUTICA PTY LTD | 2015-08-12 | — | — | CN | claimed |
| CN-103932988-A | Novel Formulation of Indomethacin | ICEUTICA PTY LTD | 2014-07-23 | — | — | CN | claimed |
| CN-103877030-A | A novel formulation of naproxen | ICEUTICA PTY LTD | 2014-06-25 | — | — | CN | claimed |
| CN-103830243-A | Method for improving the dissolution profile of a biologically active material | ICEUTICA PTY LTD | 2014-06-04 | — | — | CN | claimed |
| EP-2575807-A1 | FORMULATION BASED ON SULPIRIDE AND A SYNERGISTIC HOMEOPATHIC COMPOSITION FOR TREATMENT OF DEPRESSIVE SYNDROME | Novak, Maja (HR) | 2013-04-10 | — | — | EP | claimed |
| WO-2011148203-A1 | FORMULATION BASED ON SULPIRIDE AND A SYNERGISTIC HOMEOPATHIC COMPOSITION FOR TREATMENT OF DEPRESSIVE SYNDROME | NOVAK MAJA (HR) | 2011-12-01 | — | — | WO | claimed |
| EP-1959938-B1 | MATRIX-CONTROLLED TRANSDERMAL SYSTEM COMPRISING SALTS OF ACE INHIBITOR DICARBOXYLIC ACIDS | HEXAL AG (DE) | 2011-04-27 | — | — | EP | claimed |
| EP-1789508-B1 | METHOD OF PRODUCING A SUBSTRATE WHICH IS COATED WITH A MESOPOROUS LAYER AND USE THEREOF IN OPHTHALMIC OPTICS | ESSILOR INT (FR) | 2010-06-23 | — | — | EP | claimed |
| EP-1789508-A1 | METHOD OF PRODUCING A SUBSTRATE WHICH IS COATED WITH A MESOPOROUS LAYER AND USE THEREOF IN OPHTHALMIC OPTICS | ESSILOR INTERNATIONAL COMPAGNIE GENERALE D'OPTIQUE (FR) | 2007-05-30 | — | — | EP | claimed |
| WO-2006021698-A1 | METHOD OF PRODUCING A SUBSTRATE WHICH IS COATED WITH A MESOPOROUS LAYER AND USE THEREOF IN OPHTHALMIC OPTICS | ESSILOR INTERNATIONAL (COMPAGNIE GENERALE D'OPTIQUE) (FR) | 2006-03-02 | — | — | WO | claimed |
| EP-1100465-B1 | MEDICINAL AEROSOL FORMULATIONS | JAGO RES AG (CH) | 2004-11-24 | — | — | EP | claimed |